List of Excipients in API cimetidine hydrochloride
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing cimetidine hydrochloride
Company | Ingredient | NDC | Excipient |
---|---|---|---|
Pharmaceutical Associates Inc | cimetidine hydrochloride | 0121-0649 | ALCOHOL |
Pharmaceutical Associates Inc | cimetidine hydrochloride | 0121-0649 | FD&C YELLOW NO. 6 |
Pharmaceutical Associates Inc | cimetidine hydrochloride | 0121-0649 | HYDROCHLORIC ACID |
Pharmaceutical Associates Inc | cimetidine hydrochloride | 0121-0649 | METHYLPARABEN |
>Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for cimetidine hydrochloride
Excipient focus: ALCOHOL
cimetidine hydrochloride drug variants containing ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Pharmaceutical Associates Inc | cimetidine hydrochloride | 0121-0649 |
Chartwell RX LLC | cimetidine hydrochloride | 62135-809 |
>Company | >Ingredient | >NDC |
cimetidine hydrochloride drug variants not containing ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Akorn | cimetidine hydrochloride | 50383-966 |
Akorn Operating Company LLC | cimetidine hydrochloride oral solution | 50383-050 |
>Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
cimetidine hydrochloride drug variants containing FD&C RED NO. 40
Company | Ingredient | NDC |
---|---|---|
Chartwell RX LLC | cimetidine hydrochloride | 62135-809 |
>Company | >Ingredient | >NDC |
cimetidine hydrochloride drug variants not containing FD&C RED NO. 40
Company | Ingredient | NDC |
---|---|---|
Pharmaceutical Associates Inc | cimetidine hydrochloride | 0121-0649 |
Akorn | cimetidine hydrochloride | 50383-966 |
Akorn Operating Company LLC | cimetidine hydrochloride oral solution | 50383-050 |
>Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
cimetidine hydrochloride drug variants containing FD&C YELLOW NO. 6
Company | Ingredient | NDC |
---|---|---|
Pharmaceutical Associates Inc | cimetidine hydrochloride | 0121-0649 |
Akorn | cimetidine hydrochloride | 50383-966 |
Chartwell RX LLC | cimetidine hydrochloride | 62135-809 |
Akorn Operating Company LLC | cimetidine hydrochloride oral solution | 50383-050 |
>Company | >Ingredient | >NDC |
cimetidine hydrochloride drug variants not containing FD&C YELLOW NO. 6
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
cimetidine hydrochloride drug variants containing HYDROCHLORIC ACID
Company | Ingredient | NDC |
---|---|---|
Pharmaceutical Associates Inc | cimetidine hydrochloride | 0121-0649 |
Chartwell RX LLC | cimetidine hydrochloride | 62135-809 |
Akorn Operating Company LLC | cimetidine hydrochloride oral solution | 50383-050 |
>Company | >Ingredient | >NDC |
cimetidine hydrochloride drug variants not containing HYDROCHLORIC ACID
Company | Ingredient | NDC |
---|---|---|
Akorn | cimetidine hydrochloride | 50383-966 |
>Company | >Ingredient | >NDC |
Excipient focus: MENTHOL
cimetidine hydrochloride drug variants containing MENTHOL
Company | Ingredient | NDC |
---|---|---|
Chartwell RX LLC | cimetidine hydrochloride | 62135-809 |
>Company | >Ingredient | >NDC |
cimetidine hydrochloride drug variants not containing MENTHOL
Company | Ingredient | NDC |
---|---|---|
Pharmaceutical Associates Inc | cimetidine hydrochloride | 0121-0649 |
Akorn | cimetidine hydrochloride | 50383-966 |
Akorn Operating Company LLC | cimetidine hydrochloride oral solution | 50383-050 |
>Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN
cimetidine hydrochloride drug variants containing METHYLPARABEN
Company | Ingredient | NDC |
---|---|---|
Pharmaceutical Associates Inc | cimetidine hydrochloride | 0121-0649 |
Akorn | cimetidine hydrochloride | 50383-966 |
Chartwell RX LLC | cimetidine hydrochloride | 62135-809 |
Akorn Operating Company LLC | cimetidine hydrochloride oral solution | 50383-050 |
>Company | >Ingredient | >NDC |
cimetidine hydrochloride drug variants not containing METHYLPARABEN
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: ORANGE
cimetidine hydrochloride drug variants containing ORANGE
Company | Ingredient | NDC |
---|---|---|
Akorn | cimetidine hydrochloride | 50383-966 |
Akorn Operating Company LLC | cimetidine hydrochloride oral solution | 50383-050 |
>Company | >Ingredient | >NDC |
cimetidine hydrochloride drug variants not containing ORANGE
Company | Ingredient | NDC |
---|---|---|
Pharmaceutical Associates Inc | cimetidine hydrochloride | 0121-0649 |
Chartwell RX LLC | cimetidine hydrochloride | 62135-809 |
>Company | >Ingredient | >NDC |
Excipient focus: POLOXAMER 188
cimetidine hydrochloride drug variants containing POLOXAMER 188
Company | Ingredient | NDC |
---|---|---|
Chartwell RX LLC | cimetidine hydrochloride | 62135-809 |
Akorn Operating Company LLC | cimetidine hydrochloride oral solution | 50383-050 |
>Company | >Ingredient | >NDC |
cimetidine hydrochloride drug variants not containing POLOXAMER 188
Company | Ingredient | NDC |
---|---|---|
Pharmaceutical Associates Inc | cimetidine hydrochloride | 0121-0649 |
Akorn | cimetidine hydrochloride | 50383-966 |
>Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
cimetidine hydrochloride drug variants containing PROPYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Pharmaceutical Associates Inc | cimetidine hydrochloride | 0121-0649 |
Akorn | cimetidine hydrochloride | 50383-966 |
Chartwell RX LLC | cimetidine hydrochloride | 62135-809 |
Akorn Operating Company LLC | cimetidine hydrochloride oral solution | 50383-050 |
>Company | >Ingredient | >NDC |
cimetidine hydrochloride drug variants not containing PROPYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: PROPYLPARABEN
cimetidine hydrochloride drug variants containing PROPYLPARABEN
Company | Ingredient | NDC |
---|---|---|
Pharmaceutical Associates Inc | cimetidine hydrochloride | 0121-0649 |
Akorn | cimetidine hydrochloride | 50383-966 |
Chartwell RX LLC | cimetidine hydrochloride | 62135-809 |
Akorn Operating Company LLC | cimetidine hydrochloride oral solution | 50383-050 |
>Company | >Ingredient | >NDC |
cimetidine hydrochloride drug variants not containing PROPYLPARABEN
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SACCHARIN SODIUM
cimetidine hydrochloride drug variants containing SACCHARIN SODIUM
Company | Ingredient | NDC |
---|---|---|
Pharmaceutical Associates Inc | cimetidine hydrochloride | 0121-0649 |
Akorn | cimetidine hydrochloride | 50383-966 |
Chartwell RX LLC | cimetidine hydrochloride | 62135-809 |
Akorn Operating Company LLC | cimetidine hydrochloride oral solution | 50383-050 |
>Company | >Ingredient | >NDC |
cimetidine hydrochloride drug variants not containing SACCHARIN SODIUM
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM CHLORIDE
cimetidine hydrochloride drug variants containing SODIUM CHLORIDE
Company | Ingredient | NDC |
---|---|---|
Pharmaceutical Associates Inc | cimetidine hydrochloride | 0121-0649 |
Akorn | cimetidine hydrochloride | 50383-966 |
Akorn Operating Company LLC | cimetidine hydrochloride oral solution | 50383-050 |
>Company | >Ingredient | >NDC |
cimetidine hydrochloride drug variants not containing SODIUM CHLORIDE
Company | Ingredient | NDC |
---|---|---|
Chartwell RX LLC | cimetidine hydrochloride | 62135-809 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
cimetidine hydrochloride drug variants containing SODIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
Pharmaceutical Associates Inc | cimetidine hydrochloride | 0121-0649 |
Chartwell RX LLC | cimetidine hydrochloride | 62135-809 |
>Company | >Ingredient | >NDC |
cimetidine hydrochloride drug variants not containing SODIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
Akorn | cimetidine hydrochloride | 50383-966 |
Akorn Operating Company LLC | cimetidine hydrochloride oral solution | 50383-050 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE DIBASIC DIHYDRATE
cimetidine hydrochloride drug variants containing SODIUM PHOSPHATE DIBASIC DIHYDRATE
Company | Ingredient | NDC |
---|---|---|
Pharmaceutical Associates Inc | cimetidine hydrochloride | 0121-0649 |
>Company | >Ingredient | >NDC |
cimetidine hydrochloride drug variants not containing SODIUM PHOSPHATE DIBASIC DIHYDRATE
Company | Ingredient | NDC |
---|---|---|
Akorn | cimetidine hydrochloride | 50383-966 |
Chartwell RX LLC | cimetidine hydrochloride | 62135-809 |
Akorn Operating Company LLC | cimetidine hydrochloride oral solution | 50383-050 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
cimetidine hydrochloride drug variants containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
Company | Ingredient | NDC |
---|---|---|
Akorn | cimetidine hydrochloride | 50383-966 |
Akorn Operating Company LLC | cimetidine hydrochloride oral solution | 50383-050 |
>Company | >Ingredient | >NDC |
cimetidine hydrochloride drug variants not containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
Company | Ingredient | NDC |
---|---|---|
Pharmaceutical Associates Inc | cimetidine hydrochloride | 0121-0649 |
Chartwell RX LLC | cimetidine hydrochloride | 62135-809 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
cimetidine hydrochloride drug variants containing SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
Company | Ingredient | NDC |
---|---|---|
Chartwell RX LLC | cimetidine hydrochloride | 62135-809 |
>Company | >Ingredient | >NDC |
cimetidine hydrochloride drug variants not containing SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
Company | Ingredient | NDC |
---|---|---|
Pharmaceutical Associates Inc | cimetidine hydrochloride | 0121-0649 |
Akorn | cimetidine hydrochloride | 50383-966 |
Akorn Operating Company LLC | cimetidine hydrochloride oral solution | 50383-050 |
>Company | >Ingredient | >NDC |
Excipient focus: SORBITOL
cimetidine hydrochloride drug variants containing SORBITOL
Company | Ingredient | NDC |
---|---|---|
Pharmaceutical Associates Inc | cimetidine hydrochloride | 0121-0649 |
Akorn | cimetidine hydrochloride | 50383-966 |
Akorn Operating Company LLC | cimetidine hydrochloride oral solution | 50383-050 |
>Company | >Ingredient | >NDC |
cimetidine hydrochloride drug variants not containing SORBITOL
Company | Ingredient | NDC |
---|---|---|
Chartwell RX LLC | cimetidine hydrochloride | 62135-809 |
>Company | >Ingredient | >NDC |
Excipient focus: SORBITOL SOLUTION
cimetidine hydrochloride drug variants containing SORBITOL SOLUTION
Company | Ingredient | NDC |
---|---|---|
Chartwell RX LLC | cimetidine hydrochloride | 62135-809 |
>Company | >Ingredient | >NDC |
cimetidine hydrochloride drug variants not containing SORBITOL SOLUTION
Company | Ingredient | NDC |
---|---|---|
Pharmaceutical Associates Inc | cimetidine hydrochloride | 0121-0649 |
Akorn | cimetidine hydrochloride | 50383-966 |
Akorn Operating Company LLC | cimetidine hydrochloride oral solution | 50383-050 |
>Company | >Ingredient | >NDC |
Excipient focus: WATER
cimetidine hydrochloride drug variants containing WATER
Company | Ingredient | NDC |
---|---|---|
Pharmaceutical Associates Inc | cimetidine hydrochloride | 0121-0649 |
Akorn | cimetidine hydrochloride | 50383-966 |
Chartwell RX LLC | cimetidine hydrochloride | 62135-809 |
Akorn Operating Company LLC | cimetidine hydrochloride oral solution | 50383-050 |
>Company | >Ingredient | >NDC |
cimetidine hydrochloride drug variants not containing WATER
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.